{
    "eid": "2-s2.0-85163304152",
    "title": "Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial",
    "cover-date": "2023-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pulmonary and Respiratory Medicine",
            "@code": "2740",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Adjuvant",
        "EGFR",
        "Non\u2013small cell lung cancer",
        "Osimertinib",
        "Safety"
    ],
    "authors": [
        "Thomas John",
        "Christian Groh\u00e9",
        "Jonathan W. Goldman",
        "Frances A. Shepherd",
        "Filippo de Marinis",
        "Terufumi Kato",
        "Qun Wang",
        "Wu Chou Su",
        "Jin Hyuk Choi",
        "Virote Sriuranpong",
        "Barbara Melotti",
        "Mary J. Fidler",
        "Jun Chen",
        "Muna Albayaty",
        "Marta Stachowiak",
        "Sarah Taggart",
        "Yi Long Wu",
        "Masahiro Tsuboi",
        "Roy S. Herbst",
        "Margarita Majem"
    ],
    "citedby-count": 1,
    "ref-count": 25,
    "ref-list": [
        "AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer",
        "Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer",
        "Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC",
        "CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer",
        "CNS efficacy of osimertinib in patients with T790M-positive advanced non-small-cell lung cancer: data from a randomized phase III trial (AURA3)",
        "Osimertinib in resected EGFR-mutated non-small-cell lung cancer",
        "Adjuvant osimertinib for resected EGFR-mutated stage IB\u2012IIIA NSCLC: updated results from the phase III randomized ADAURA trial",
        "Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study",
        "Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial",
        "Extending aromatase-inhibitor adjuvant therapy to 10 years",
        "Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human epidermal growth factor Receptor (HER2) overexpressing breast cancer",
        "Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women",
        "The role of EGFR-TKIs as adjuvant therapy in EGFR mutation-positive early-stage NSCLC: a meta-analysis",
        "Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials",
        "Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis",
        "Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer",
        "TAGRISSO\u00ae (osimertinib). Summary of product characteristics",
        "TAGRISSO\u00ae (osimertinib). Highlights of prescribing information",
        "Health-related quality of life outcomes in patients with resected epidermal growth factor receptor-mutated non-small cell lung cancer who received adjuvant osimertinib in the phase III ADAURA trial",
        "User's Manual for the SF-36v2 Health Survey",
        "Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up",
        "Adjuvant erlotinib versus placebo in patients with stage IB-IIIA non-small-cell lung cancer (RADIANT): a randomized, double-blind, phase III trial",
        "Randomized phase III study of gefitinib versus cisplatin plus vinorelbine for patients with resected stage II-IIIA non-small-cell lung cancer with EGFR mutation (IMPACT)",
        "Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials"
    ],
    "affiliation": [
        {
            "affiliation-city": "Cambridge",
            "@id": "60004219",
            "affilname": "AstraZeneca",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004219",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60069718",
            "affilname": "Guangdong Provincial People\u2019s Hospital of Southern Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069718",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60033129",
            "affilname": "Peter Maccallum Cancer Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033129",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60030442",
            "affilname": "Istituto Europeo di Oncologia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030442",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60029305",
            "affilname": "Ajou University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029305",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60027817",
            "affilname": "Princess Margaret Cancer Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027817",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60026553",
            "affilname": "University of Melbourne",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bologna",
            "@id": "60024574",
            "affilname": "IRCCS Azienda Ospedaliero-Universitaria di Bologna",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024574",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chicago",
            "@id": "60018691",
            "affilname": "Rush University Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018691",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New Haven",
            "@id": "60017994",
            "affilname": "Yale School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017994",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Yokohama",
            "@id": "60017631",
            "affilname": "Kanagawa Cancer Center Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017631",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Tainan",
            "@id": "60014982",
            "affilname": "National Cheng Kung University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014982",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Tianjin",
            "@id": "60011715",
            "affilname": "Tianjin Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011715",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Kashiwa",
            "@id": "60010925",
            "affilname": "National Cancer Center Hospital East",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60009860",
            "affilname": "Fudan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009860",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "60009466",
            "affilname": "Hospital de La Santa Creu I Sant Pau",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009466",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Los Angeles",
            "@id": "60005247",
            "affilname": "David Geffen School of Medicine at UCLA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005247",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Berlin",
            "@id": "112642958",
            "affilname": "Evangelische Lungenklinik Berlin-Buch",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112642958",
            "affiliation-country": "Germany"
        }
    ],
    "funding": [
        "Masahiro Tsuboi",
        "Roy S. Herbst",
        "AstraZeneca"
    ]
}